-
-
-
-
-
-
-
Cogent Biosciences launches $400 million dual offering of notes and stock
-
-
-
-
-
-
-
Jefferies Assumes Cogent (COGT) at Buy, 'A Validated Tool "KIT" for Mast Cell Diseases & GI Cancer'
-
-
-
-
-
-
-
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
-
-
-
-
-
-
-
Cogent Biosciences (COGT) Announces $125M Share Offeirng
-
-
-
-
-
-
-
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
-
-
-
-
-
-
-
Notable Analyst Rating Changes 02/01: BIDU, ALV, G, ARG, ASH Upgraded; CPF, M, LZ, COGT, WCRX Downgraded
72,322 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

